Diagnostic advances in defining erythropoietic abnormalities and red blood cell diseases.
The majority of clinical applications of flow cytometry begin with various approaches to remove red blood cells (RBCs) from the clinical sample. However, multiparameter cytometry has and will continue to contribute much to the understanding of the pathophysiology and diagnostic accuracy in the clinical evaluation of human diseases affecting erythroid cells. This review summarizes the diagnostic advances relating to erythroid cells in the areas of immunohematology, laboratory hematology, and infectious disease with particular emphasis on medical evaluation of the anemic patient and fetomaternal hemorrhage. Semin Hematol 38:148-159.
Davis
B H
BH
Maine Medical Center Research Institute, Scarborough, ME 04074, USA.
D000818:Animals; D004913:Erythrocytes, Abnormal / Q000276:immunology / Q000382:microbiology; D004920:Erythropoiesis / Q000276:immunology*; D005434:Flow Cytometry / Q000379:methods; D006402:Hematologic Diseases / Q000175:diagnosis*; D006801:Humans; D016130:Immunophenotyping / Q000379:methods